Mednet Logo
HomeAllergy & Immunology
Allergy & Immunology

Allergy & Immunology

Expert discussions on allergic conditions, immunodeficiencies, drug hypersensitivity, and immunotherapy approaches.

Recent Discussions

How do you approach treating patients who develop psoriasis while on Dupixent?

8
2 Answers

Mednet Member
Mednet Member
Dermatology · Case Western Reserve University

Stop the Dupixent. These patients likely had a non-Th2 driven type of dermatitis e.g. Malassezia yeast hypersensitivity, which is Th17 driven, or stasis dermatitis with autoeczematization, or eczematous drug reaction. Revisit the Diagnostic Checklist for Generalized Dermatitis.

Do you diagnose MCAS if a patient is concurrently on drugs known to cause non-specific mast cell degranulation?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Brigham And Womens Hospital Respiratory Immunology Lab

Yes, MCAS may be diagnosed if a patient is on drugs known to cause non-specific mast cell activation.The reason for this answer requires a better understanding of MCAS criteria and etiology. In 2022, an expert consortium proposed revisions to the classification of mast cell activation disorders. (Va...

Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?

2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Mississippi School of Medicine

Given, as noted above, no significant clinical differences between benralizumab and mepolizumab, assuming there are no specific insurance differences between the two, I preferentially prescribe benralizumab because of the 8-week dosing frequency after the first three 4-week loading doses. For a few ...

Do you scale up 2nd generation anti-histamines to 4x daily in acute urticaria in the pediatric population as you do in adults?

2
2 Answers

Mednet Member
Mednet Member
Dermatology · University of South Florida Morsani College of Medicine

Severe urticaria is certainly a therapeutic challenge. Updosing 2nd generation antihistamines in children has been studied, more trials need to be done. For refractory urticaria in children, I will often recommend 2X the recommended dose of a 2nd generation antihistamine in the morning and maximize ...

Is the timing of childhood eczema onset useful as a prognostic factor in predicting food allergy tolerance?

1
2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Maryland School of Medicine

It is the case that eczema and food allergy are correlated comorbidities. Studies have demonstrated that the age of presentation of the eczema may affect the development of food allergy. The HealthNuts study in Australia was a prospective cohort study looking specifically at the development of the a...

Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?

1
1 Answers

Mednet Member
Mednet Member
Infectious Disease · National Institute of Allergy and Infectious Diseases (NIAID)

There is no good-quality evidence supporting a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients. The efficacy of nitazoxanide in viral gastroenteritis is supported by a small manufacturer-sponsored randomized, double-blind trial in non-immunocompromised ...

When would you suspect an allergy to the dialysis membrane in patients who complain of pruritis during dialysis?

2
2 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

The short answer is no. Pruritus is so common with renal disease, and allergic reactions to dialyzers are uncommon. If the pruritus can confidently be documented to be only during dialysis and not at any other time, then it may be worth trying a different dialyzer but it would take a lot for me to b...

Are you increasing the dose and/or frequency of Xolair administration if patients have failed standard dosing for CSU?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · PennState Health

The data with omalizumab is clear that updosing is safe and effective. Dupilumab, omalizumab, and remibrutinib are all about equally effective (about 60%), but updosing omalizumab to 300 every 2 weeks and even to 600 every 2 weeks gives a 60% benefit to the 40% that fail 300 a month.

Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?

13
6 Answers

Mednet Member
Mednet Member
Neurology · Cedars-Sinai Medical Center

Interesting question. Not being an endocrinologist, I don't have the expertise to advise but the reference below makes the statement that even short-term steroids can be an issue. I suspect that if you have to stop abruptly from 60 mg daily for 2 weeks, it would probably be fine in most instances bu...

Is it necessary to test for all tree nuts when a patient presents with IgE mediated symptoms to an isolated tree nut?

2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Maryland School of Medicine

Having an allergy to a specific tree nut does not mean a patient will be allergic to others, but there are some that are cross-reactive, and it may be worthwhile testing for the cross-reactive tree nut as opposed to testing for all. For example, if the patient had a reaction to cashew, testing for p...